Advertisement

Structural basis for the signal transduction of erythropoietin

  • Timothy Osslund
  • Rashid Syed
Part of the Milestones in Drug Therapy MDT book series (MDT)

Keywords

Darbep Oetin Alfa Helical Bundle Bury Surface Area Rece Ptor Potent Mimetics 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Syed RS, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang J et al. (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395: 511–516CrossRefPubMedGoogle Scholar
  2. 2.
    Cheetham JC, Smith DM, Aoki KH, Stevenson JL, Hoeffel TJ, Syed RS, Egrie J, Harvey TS (1998) NMR structure of human erythropoietin and a comparison with its receptor bound conformation. Nat Struct Biol 5: 861–866CrossRefPubMedGoogle Scholar
  3. 3.
    Bazan JF (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87: 6934–6938PubMedGoogle Scholar
  4. 4.
    D’Andrea AD, Lodish HF, Wong GG (1989) Expression cloning of the murine erythropoietin receptor. Cell 57: 277–285Google Scholar
  5. 5.
    Philo JS, Aoki KH, Arakawa T, Narhi LO, Wen J (1996) Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: One high-affinity and one low-affinity interaction. Biochemistry 35: 1681–1691CrossRefPubMedGoogle Scholar
  6. 6.
    Damen JE, Krystal G (1996) Early events in erythropoietin-induced signaling. Exp Hematol 24: 1455–1459PubMedGoogle Scholar
  7. 7.
    Yoshimura A, Longmore G, Lodish HF (1990) Point mutation in the exo-plasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 348: 647–649CrossRefPubMedGoogle Scholar
  8. 8.
    Elliott S, Lorenzini T, Yanagihara D, Chang D, Elliott G (1996) Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies. J Biol Chem 271: 24691–24697PubMedGoogle Scholar
  9. 9.
    Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ (1996) Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273: 458–464PubMedGoogle Scholar
  10. 10.
    Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA (1996) Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 A. Science 273: 464–471PubMedGoogle Scholar
  11. 11.
    Wrighton NC, Balasubramanian P, Barbone FP, Kashyap AK, Farrell FX, Jolliffe LK, Barrett RW, Dower WJ (1997) Increased potency of an erythropoietin peptide mimetic through covalent dimerization. Nat Biotechnol 15: 1261–1265CrossRefPubMedGoogle Scholar
  12. 12.
    Naranda T, Wong K, Kaufman RI, Goldstein A, Olsson L (1999) Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site. Proc Natl Acad Sci USA 96: 7569–7574CrossRefPubMedGoogle Scholar
  13. 13.
    Constantinescu SN, Keren T, Socolovsky M, Nam H, Henis YI, Lodish HF (2001) Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci USA 98: 4379–4384CrossRefPubMedGoogle Scholar
  14. 14.
    Narhi LO, Arakawa T, Aoki K, Wen J, Elliott S, Boone T, Cheetham J (2001) Asn to Lys mutations at three sites which are N-glycosylated in the mammalian protein decrease the aggregation of Escherichia coli-derived erythropoietin. Protein Eng 14: 135–140PubMedGoogle Scholar
  15. 15.
    Bazan JF (1990) Haemopoietic receptors and helical cytokines. Immunol Today 11: 350–354CrossRefPubMedGoogle Scholar
  16. 16.
    Hill CP, Osslund TD, Eisenberg D (1993) The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. Proc Natl Acad Sci USA 90: 5167–5171PubMedGoogle Scholar
  17. 17.
    Hilton DJ, Watowich SS, Katz L, Lodish HF (1996) Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. J Biol Chem 271: 4699–4708CrossRefPubMedGoogle Scholar
  18. 18.
    Barbone FP, Middleton SA, Johnson DL, McMahon FJ, Tullai J, Gruninger RH, Schilling AE, Jolliffe LK, Mulcahy LS (1997) Mutagenesis studies of the human erythropoietin receptor. Establishment of structure-function relationships. J Biol Chem 272: 4985–4992PubMedGoogle Scholar
  19. 19.
    Johnson DL, Middleton SA, McMahon F, Barbone FP, Kroon D, Tsao E, Lee WH, Mulcahy LS, Jolliffe LK (1996) Refolding, purification, and characterization of human erythropoietin binding protein produced in Escherichia coli. Protein Expr Purif 7: 104–113PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag/Switzerland 2003

Authors and Affiliations

  • Timothy Osslund
    • 1
  • Rashid Syed
    • 1
  1. 1.Amgen Inc.Thousand OaksUSA

Personalised recommendations